Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Blood Advances|February 24, 2025
A roadmap for uniform comprehensive long- term follow up after curative therapy for sickle cell diseaseShalini Shenoy, Julie Kanter, Adetola A Kassim, et al.
Annals of the American Thoracic Society|August 27, 2024
Pulmonary Function after Nonmyeloablative Hematopoietic Cell Transplant for Sickle Cell DiseaseA Parker Ruhl, Ruba Shalhoub, Neal Jeffries, et al.
JAMA|July 25, 2014
Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotypeMatthew M Hsieh, Courtney D Fitzhugh, R Patrick Weitzel, et al.
Frontiers in Immunology|October 1, 2024
Galectin-1 is associated with hematopoietic cell engraftment in murine MHC-mismatched allotransplantationAhmad Shaikh, Arunakumar Gangaplara, Abdoul Kone, et al.
Blood Advances|January 4, 2018
Cyclophosphamide improves engraftment in patients with SCD and severe organ damage who undergo haploidentical PBSCTCourtney D Fitzhugh, Matthew M Hsieh, Tiffani Taylor, et al.
The New England Journal of Medicine|December 17, 2009
Allogeneic hematopoietic stem-cell transplantation for sickle cell diseaseMatthew M Hsieh, Elizabeth M Kang, Courtney D Fitzhugh, et al.
Neurology|May 14, 2026
Hematopoietic Stem Cell Transplant and Brain Volume Changes in Adults With Sickle Cell DiseaseKyle C Kern, Zaina Inam, Matthew M Hsieh, et al.
The Pediatric Infectious Disease Journal|February 19, 2008
Triad of severe abdominal pain, inappropriate antidiuretic hormone secretion, and disseminated varicella-zoster virus infection preceding cutaneous manifestations after hematopoietic stem cell transplantation: utility of PCR for early recognition and therapyRachel Rau, Courtney D Fitzhugh, Kristin Baird, et al.
Journal of Clinical Pharmacology|July 17, 2020
Computer Algorithm-Based Hydroxyurea Dosing Facilitates Titration to Maximum Tolerated Dose in Sickle Cell AnemiaMahogany Oldham, Anna Conrey, Corinne Pittman, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2025
Recipient Cells Are the Source of Hematologic Malignancies After Graft Failure and Mixed Chimerism in Adults with SCDMohamed A E Ali, Emily M Limerick, Matthew M Hsieh, et al.
Pageof 6